Podcasts about Nephrology

The FiltrateJoel Topf kidneyboy.bsky.socialSpecial GuestsDr. Samir Parikh, President of the American Society of NephrologyProf. Donal Reddan, President, Irish Nephrology SocietyProf. Catherine GodsonEditing Joel TopfThe Kidney Connection written and performed by Timothy YauShow Notes Tubular SecretionsJoel Topf, the Dublin Port Greenway LinkCatherine Godson: never heard of the Dublin Port GreenwaySamir Parikh: Trinity College Dublin and specifically the Eavan Boland Library, named after the Irish poet. Donal Reddan: Something about rugby

This ASN Kidney Translation Podcast episode covers advances in artificial intelligence: ASN Workgroup on AI (JASN), AI in nephrology education (CJASN), and ethical issues in AI (K360).

Guest: John W. Ostrominski, MD, MPH Despite advances in glycemic management, blood pressure control, lipid lowering, and disease-modifying therapies, patients with chronic kidney disease (CKD) and type 2 diabetes continue to face substantial residual cardiovascular risk. In this program, Dr. John Ostrominski reviews emerging evidence linking low-grade systemic inflammation to adverse cardiovascular outcomes in this high-risk population, highlighting findings from the FIDELITY pooled analysis of FIDELIO-DKD and FIGARO-DKD. Dr. Ostrominski is a fellow specializing in cardiovascular disease and obesity medicine at Brigham and Women's Hospital and Harvard Medical School. He spoke about this topic at the 2026 American Diabetes Association Scientific Sessions.

Richard Glassock, MD, reflects on decades of advances in kidney diseases and discusses the future of glomerular disease, biomarkers, clinical trials, and prevention with host Andrew Cohen, MD. 

Richard Glassock, MD, reflects on decades of advances in kidney diseases and discusses the future of glomerular disease, biomarkers, clinical trials, and prevention with host Andrew Cohen, MD. 

Karandeep Singh, MD, speaks with Karin Bergling, MD, and Wisit Cheungpasitporn, MD, about the AI-Powered Kidney Care Network, an ASN Community for those with medical and technical backgrounds interested in AI and its applications in kidney care.

Karandeep Singh, MD, speaks with Karin Bergling, MD, and Wisit Cheungpasitporn, MD, about the AI-Powered Kidney Care Network, an ASN Community for those with medical and technical backgrounds interested in AI and its applications in kidney care.

What is cultural distress? It is a negative response rooted in a cultural conflict where the patient lacks control over their situation. It results in more physiologic effects on the body resulting in allostatic overload. To prevent this, healthcare practitioners must use strategies such as cultural humility to help patients navigate healthcare. Come find the best ways to deliver culturally sensitive care in any setting.

In this episode, we explore the major complications of acute kidney injury (AKI) and break down the different modalities of dialysis used in the ICU and inpatient setting.Join us for a high-yield, clinically focused discussion covering AKI complications, and the practical differences between intermittent hemodialysis (HD), peritoneal dialysis (PD), and continuous renal replacement therapy (CRRT).Hosts:Dr. Tanya S. Jain and Dr. Avtandil Kochiashvili, Chief Medical Residents, UConnGuest Expert:Dr. Lalarukh Haider, Assistant Professor of Medicine, Division of Nephrology, UConn Health and Program Director of Nephrology FellowshipAuthor:Dr. Tanya S. Jain, Chief Medical Resident, UConnEdited by:Dr. Avtandil Kochiashvili, Chief Medical Resident, UConnMusic:LoFi Girl by Snoozy Beats | Free Music Archive | License: CC BY

ASN Executive Vice President and Chief Executive Officer Tod Ibrahim explores the history of eGFR with Andrew Levey, MD, Tom Hostetter, MD, and Crystal Gadegbeku, MD. Hear how policy, equity, and care have evolved, and what future assessments demand.

ASN Executive Vice President and Chief Executive Officer Tod Ibrahim explores the history of eGFR with Andrew Levey, MD, Tom Hostetter, MD, and Crystal Gadegbeku, MD. Hear how policy, equity, and care have evolved, and what future assessments demand.

This session will discuss the rising demand for kidney care, key causes of workforce gaps, and the impact on patient outcomes. It would also highlight practical solutions to strengthen the nephrology nursing workforce.Moderator: Ana Figueiredo Speakers:Rachael WalkerMarques Shek Nam NgGinger ChuLaura Lunardi 

Guest: Jeanette Andrade, PhD, RDN, LDN, FAND Food and nutrition insecurity are increasingly recognized as critical factors affecting outcomes for patients with chronic kidney disease (CKD). That's why Dr. Jeanette Andrade joins us to share practical screening strategies and emerging solutions, like dialysis center food pantries and digital health tools. Dr. Andrade is an Associate Professor and the Director of the Master's in Dietetic Internship Program at the University of Florida, and she spoke about this topic at the 2026 National Kidney Foundation Spring Clinical Meeting.

Guest: Abdallah Geara, MD IgA nephropathy is often asymptomatic and frequently identified through incidental lab findings, making timely recognition challenging. Hear Dr. Abdallah Geara discuss key diagnostic strategies that may help optimize long-term care for this disease. Dr. Geara is an Associate Professor of Clinical Medicine and the Clinical Director of the Glomerular Disease Program at the Perelman School of Medicine at the University of Pennsylvania, and he spoke at the 2026 National Kidney Foundation Spring Clinical Meeting.

Guest: Abdallah Geara, MD Early diagnosis is critical in IgA nephropathy, as most patients present with established kidney damage by the time they are identified. Tune in to hear Dr. Abdallah Geara highlight the importance of timely recognition and how emerging therapies are transforming treatment and improving patient outcomes when implemented early.

Guest: Jeanette Andrade, PhD, RDN, LDN, FAND Food and nutrition insecurity in chronic kidney disease (CKD) can be difficult to detect, even when patients appear clinically stable. To help highlight this challenge, Dr. Jeanette Andrade presents a case from her research illustrating how social and financial stressors affected a dialysis patient's dietary intake and food access. Dr. Andrade is an Associate Professor and the Director of the Master's in Dietetic Internship Program at the University of Florida, and this patient case was part of her presentation at the 2026 National Kidney Foundation Spring Clinical Meeting.

Guest: Deborah Clegg, PhD For decades, potassium restriction has been a cornerstone of dietary management in patients with chronic kidney disease (CKD), but is it always necessary? Here to answer that exact question is Dr. Deborah Clegg. Since many patients may already be consuming potassium at restricted levels, she emphasizes the importance of individualized dietary assessment before imposing further limitations. Dr. Clegg is the Vice President for Research and a Professor in the Department of Internal Medicine at Texas Tech University Health Sciences Center in El Paso.

This ISN i3C podcast brings together leading ISN experts to unpack a new paper tackling one of nephrology's biggest mysteries: chronic kidney disease of unknown origin (CKDu). The discussion explores why identifying the causes of CKDu has been so challenging—highlighting gaps in terminology, study design, and data collection—while questioning whether current research approaches are asking the right questions. Through expert insights and debate, the podcast emphasizes the need for standardized methods, stronger global collaboration, and a shift toward translating research into prevention, especially in low- and middle-income countries. The podcast closes by looking ahead to priority research areas and how the global community can get involved in advancing solutions. Listeners will come away with a deeper, more nuanced understanding of CKDu.Participants: Ben Caplin (UK), ISN i3C Working Group ChairMagdalena Madero (Mexico), ISN i3C Working Group Deputy ChairEranga Wijewickrama (Sri Lanka)Shuchi Anand (United States) 

Guest Dr. Jeffrey Perl joins host Dr. Tushar Chopra to explore strategies to prevent peritoneal dialysis infections, address gaps in practice, review infection trends, and discuss opportunities for progress through collaboration and team-based care.

Guest Dr. Jeffrey Perl joins host Dr. Tushar Chopra to explore strategies to prevent peritoneal dialysis infections, address gaps in practice, review infection trends, and discuss opportunities for progress through collaboration and team-based care.

In this episode of the RCP Medicine Podcast, Professor Jeremy Levy, consultant nephrologist in London, joins Dr Alex Crowe, consultant physician in Liverpool, for an insightful and practical conversation about chronic kidney disease (CKD). Together, they explore why CKD is so common, and often silent. How to distinguish acute from chronic kidney problems, and which investigations matter most.The discussion also highlights the growing importance of cardiorenal metabolic medicine, offering clinicians a clear approach to assessing risk, optimising treatment, and supporting long‑term health. From EGFR trends to SGLT2 inhibitors, from lifestyle change to coding accuracy, this episode provides an essential, up‑to‑date guide for managing CKD in everyday practice.Resources For kidney sake podcast:  Home | ForKidneysSake.com Excellent resources on CKD here from NHS NW London:  Chronic kidney diseaseNICE guidelines: Overview | Chronic kidney disease: assessment and management | Guidance | NICE Hypertension in CKD from UK kidney association  FINAL UKKA NICE-KDIGO commentary December 2022.pdfExercise and Lifestyle in CKD from UK kidney association   Exercise and Lifestyle in CKD clinical practice guideline33_v4_FINAL_0.pdf SGLT2i in CKD  from UK kidney association  Sodium Glucose Co transporter 2 - UK Kidney Association.KDIGO (international) guidelines on CKD management   CKD Evaluation and Management – KDIGOKIDGO prognosis of CKD by Albuminuria Categories: KIDGO 2012 S126American Diabetes Association guidelines including CKD   Volume 48 Issue Supplement_1 | Diabetes Care | American Diabetes AssociationFor Kidneys SakeFor Kidneys Sake is a clinician-led podcast from Imperial College Healthcare NHS Trust and North West London Integrated Care Board, offering practical, evidence-based insight into chronic kidney disease and cardio-renal care. Through short, accessible conversations with experts across primary and secondary care, the series supports shared learning on CKD detection, risk management and integrated patient care. The podcast is for GPs, pharmacists, nurses and multidisciplinary teams, and is relevant for clinicians, patients and anyone interested in improving kidney health.Explore our CPD portfolio by your career stageRCP | Education and professional developmentRCP LinksEducationRCP Social MediaInstagramLinkedInFacebookBlueskyMusic Episode 50 onward - Bensound.com  Episodes 1 - 49 'Impressive Deals' - Nicolai Heidlas Any adverts within this podcast may use computer generated voices

CME credits: 0.25 Valid until: 07-04-2027 Claim your CME credit at https://reachmd.com/programs/cme/transforming-care-in-pediatric-patients-with-c3-glomerulopathy-targeting-c3-at-the-source/54143/ Complement-mediated kidney diseases such as C3 glomerulopathy (C3G) continue to present significant diagnostic and therapeutic challenges in nephrology for both adult and pediatric patients. Among children, this rare disease can progress to end-stage kidney disease within 10 years of diagnosis. Traditional treatment options include supportive care and immunotherapies, but both approaches are only modestly effective in reducing proteinuria. The approval of complement inhibitors, particularly those directed to C3, is a major treatment advance for C3G, revolutionizing the care of patients in this setting. In this activity, experts in the field of nephrology review the clinical evidence for these therapies and offer practical tips regarding their optimal use in pediatric patients.=

CME credits: 0.25 Valid until: 31-03-2027 Claim your CME credit at https://reachmd.com/programs/cme/stuck-on-antihistamines-for-managing-patients-with-ckd-ap-time-to-reconsider/37607/ Despite effective and recommended therapies, many healthcare providers still consider antihistamines as the first-choice treatment for CKD-associated pruritus. Join Drs. Antoine Lanot and Gil Yosipovitch as they review a clinical patient case from a multidisciplinary perspective and consider best practices for the diagnosis, treatment, and management of CKD-aP.=

The FiltrateJoel Topf kidneyboy.bsky.socialPedro Teixeira @nephcrit.bsky.socialNayan Arora @captainchloride.bsky.socialAnna Gaddy @annagaddy.bsky.social Swapnil Hiremath @hswapnil.medsky.social and on LinkedInSpecial GuestsIan McCoy, MD @NephroNinja study author and UCSFChi-yuan Hsu Senior author and Chief of the Division of Nephrology at UCSFSamuel Silver Associate Professor at Queens University in CanadaEditingVipin Verghese and Joel TopfShow Notes NephJC Discusion: Dialyze Less, Recover More? AKI's Chance to Get LIBERATE-DManuscript: A Conservative Dialysis Strategy and Kidney Function Recovery in Dialysis-Requiring Acute Kidney InjuryThe Liberation From Acute Dialysis (LIBERATE-D) Randomized Clinical Trial JAMA | PubMedBen's pilot study: RAD-AKI Pilot study: Recovery After Dialysis-Requiring Acute Kidney Injury (RAD-AKI) (ClinicalTrials.gov)STARRT-AKI NephJC Editorial in JAMA: A-E-I-O-U and Sometimes Why—Dialysis in Acute Kidney Injury (JAMA)What Is Dialytrauma? (Nephrology Times)How Fragile Are the Results of a Trial? The Fragility Index (PubMedCentral)Shiffl Trial: Daily Hemodialysis and the Outcome of Acute Renal Failure (NEJM)AKIKI: Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit (NEJM)AKIKI2: How Late it was, How Late! (NephJC)Sam Silver's study: Promoting Kidney Recovery After Acute Kidney Injury Receiving Dialysis (Recover-AKI) (ClinicalTrial.Gov)Marie Kondo (Wikipedia)Tubular SecretionsSwap: The smutty dragon novels of novels of Rebecca Yarros (Wikipedia) Specifically The Empyrean seriesAnna: Brisket recipesPedro: The Naked Gun (Wikipedia) with Liam NeesonIan: ASN Kidney Health Guidance on the Outpatient Management of Patients with Dialysis-Requiring Acute Kidney Injury (PubMed) he really doesn't get Tubular Secretions.Nayan: Tilt: A Novel by Emma Pattee (Amazon)Chi: The Year of Magical Thinking by Joan Didion (Wikipedia) and Innovations in Nephrology (Springer Nature)Sam: Monopoly Super Electronic Banking Board Game (Amazon)Joel: Song Sung Blue (Wikipedia)

In this episode, host Dr. Srinath Yadlapalli and guest Dr. Kristina Bryant discuss measles' diagnosis, prevention, management, and how dialysis centers can prepare for outbreaks.

In this episode, host Dr. Srinath Yadlapalli and guest Dr. Kristina Bryant discuss measles' diagnosis, prevention, management, and how dialysis centers can prepare for outbreaks.

Small yet mighty! That could best describe your kidneys and Dr. Thomas Chen, Chief of Nephrology at Kaiser Permanente Hawaii, talks kidney disease and simple ways to get on track to more healthy living. Cheri Sepasi, Member Education Specialist with Kaiser Permanente Hawaii, shares how members can get lifestyle recommendations on food menus, recipes, exercise routines, and also group support.March is National Kidney MonthKathy With a K is your host[image: left to right - Kathy With a K, Cheri Sepasi, Dr. Thomas Chen]"Hawaii Matters", a public service community program that airs on Sundays at 6:30 a.m. Hawaii across ⁠Pacific Media Group Oahu⁠ radio stations:⁠KDDB 102.7 Da Bomb⁠ |⁠ KQMQ HI93⁠ | ⁠KUMU 94.7 KUMU⁠ | ⁠KPOI 105.9 The Wave⁠ To be featured or for inquiries on "Hawaii Matters", please email: kathywithak@1059thewavefm.comRecorded on March 5, 2026 at Pacific Media Group Oahu in Honolulu, HI 96813

Providing primary health care in a war zone presents some extraordinary challenges. This presentation delves into the complex world of healthcare delivery amid conflict and chaos.

Drs. Michael Amirian and Kavita Gupta discuss what patients should know about the prevention and treatment of kidney stones. The panelists provide an overview of the symptoms and risk factors of the condition, including lifestyle choices and diet. They also highlight the crucial information on prevention strategies for better kidney health. For those who may be experiencing kidney stones, the doctors also discuss pain management and recovery steps for passing stones. To schedule with Dr. Michael J. AmirianTo schedule with Dr. Kavita Gupta

Join us for the discussion on the treatment and management of hyperphosphatemia or high phosphorus levels in the blood, a common challenge experienced by people living with chronic kidney disease on dialysis. This episode is supported by Ardelyx.   In this episode we heard from:  Dr. Annabel Biruete is an Assistant Professor and Registered Dietitian in the Department of Nutrition Science at Purdue University and an Adjunct Assistant Professor in the Division of Nephrology at the Indiana University School of Medicine. Her broad clinical interest is nutrition in kidney diseases. Dr. Biruete's research aims to study the effects of nutritional and pharmacological therapies for chronic kidney disease on the gastrointestinal tract and gut microbiome. Additionally, Dr. Biruete is interested in improving outcomes in the Hispanic/LatinX community living with chronic kidney disease, primarily targeting nutritional interventions using language- and culturally-concordant lifestyle educational materials. Melissa Tuff has been living with chronic kidney disease for 30 years. Her journey began in 1996 on her 17th birthday when she “crashed” into dialysis following a misdiagnosed UTI. She was on in-center hemodialysis for 9 and a half years until she received a life-changing kidney transplant that lasted 11 years. In 2016 her kidney rejected and since then, she continued treatment with 4 years of peritoneal dialysis and 6 years of solo home hemodialysis. She utilizes her Social Media pages for digital education & patient empowerment by hosting educational TikTok Live sessions while performing solo home hemodialysis; offering real-time insight into dialysis life and empowering others to take an active role in their treatment. Her goal is to build a support community and reduce the stigma around kidney disease by fostering open, educational, and uplifting conversations online while providing resources and guidance as to how one can live long and well on dialysis. Dr. Jaime Uribarri is a practicing nephrologist and clinical investigator in NYC. He has been in the Icahn School of Medicine at Mount Sinai, NYC, since 1990, where he is currently Professor of Medicine and Director of the Renal Clinic and the Home Dialysis Program at the Mount Sinai Hospital. In parallel with his clinical activities, Dr Uribarri has been very active in clinical investigation for more than 40 years. His main areas of research have been on acid-base and fluid and electrolytes disorders as well as nutrition in chronic kidney disease and diabetic patients. He has published well over 200 peer-reviewed papers, written many chapters in books and edited several books. He has lectured extensively on these research topics in New York City as well as in national and international meetings.   Additional Resources High Phosphorus Mineral and Bone Disorder (CKD-MBD) Secondary Hyperparathyroidism (SHPT) ASN Kidney Health Guidance on Potassium and Phosphorus Food Additives   Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.

Hosts Karandeep, MD, and Navdeep Tangri, MD, explore how machine learning regression and predictive AI impact patient care by examining importance factors, support vector machines, data training, and ways to improve prediction accuracy.

Hosts Karandeep, MD, and Navdeep Tangri, MD, explore how machine learning regression and predictive AI impact patient care by examining importance factors, support vector machines, data training, and ways to improve prediction accuracy.

Send us Fan MailPaper Discussed in this Episode:Assessing interstitial fibrosis and tubular atrophy in kidney biopsies artificial intelligence versus humans. Farris AB, Zukić D, Solez K. Current Opinion in Nephrology and Hypertension. March 16, 2026.Episode Summary: In this journal club deep dive on the Digital Pathology Podcast, we explore the intense debate over quantifying chronic kidney disease progression. We unpack a fresh 2026 study comparing artificial intelligence to human pathologists in assessing interstitial fibrosis and tubular atrophy. If top experts can't agree on a diagnosis due to human subjectivity, can an AI trained on their imperfect data provide a better standard? We explore what happens when pixel-perfect machines clash with nuanced human medical judgment.In This Episode, We Cover:• The Clinical Stakes of Kidney Scarring: Why interstitial fibrosis (the scarring of tissue spaces between filtering units) and tubular atrophy (shrinking and collapsing functional tubes) are the primary surrogate measures for tracking chronic kidney disease. We discuss how a mere 10% diagnostic variance can drastically alter a patient's medication regimen, dialysis prep, or transplant eligibility.• The Flaw in the "Gold Standard": We break down the "interobserver variability" problem—why two highly trained, board-certified pathologists can look at the exact same biopsy slide and give two completely different mathematical assessments of the damage.• How the AI Actually Works (Mapping the Neighborhood): A look at "indirect assessment through kidney compartment segmentation," where the AI acts as a digital surveyor. It identifies cellular fences like glomeruli and tubules, establishing microscopic "zoning laws" before it begins counting the damaged tissue.• The Proofreader vs. The Literary Critic: Why studies show a persistent "lack of complete concordance" between human and machine. We discuss how AI hyper-focuses on mathematical pixel intensity and mistakes physical slide artifacts (like a folded piece of tissue) for severe disease. Meanwhile, human pathologists act as "literary critics," easily filtering out the visual noise using clinical context.• The Humans + AI Synergy: The ultimate endgame isn't replacing pathologists, but combining the tireless mathematical consistency of AI with the complex contextual reasoning of humans to create a highly advanced co-pilot system.Key Takeaway: The lack of perfect agreement between AI and human pathologists isn't a failure, but rather evidence that they perform fundamentally different types of analysis. AI excels at tedious, reproducible quantification that eliminates human visual fatigue, but it lacks contextual judgment. By adopting a "humans + AI" workflow, the medical field can stabilize crucial kidney measurements and elevate the pathologist to a true diagnostic synthesizer, ultimately leading to more effective patient careSupport the showGet the "Digital Pathology 101" FREE E-book and join us!

Send us Fan MailDr. Caitlin Carter, Clinical Director of Nephrology at Rady Children's Hospital and associate clinical professor at UC San Diego, joins the podcast to challenge how neonatologists recognize and follow up on acute kidney injury. She explains why creatinine alone is insufficient, how biomarkers like NGAL can detect tubular injury before function declines, and why AKI too often disappears from the discharge summary. She also outlines published consensus guidelines on post NICU nephrology follow-up, with clear thresholds based on gestational age and AKI severity.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!

In our March episode, we truly celebrated National Kidney Month with Dr. Kristin Meliambro, an Associate Professor in the Department of Medicine at the Icahn School of Medicine at Mount Sinai. Dr. Meliambro discussed the many vital jobs kidneys perform, the causes and symptoms of kidney disease, and preventive measures that can help keep them healthy. In this month's Key Note, Dr. Meliambro walks us through the latest innovations that are making dialysis – the necessary treatment for those living with Stage 5 kidney disease – more manageable.   The Takeaway We want to hear from you! Please complete our survey: org/member-feedback. Drop us a line at our social media channels: Facebook// Instagram // YouTube. Find out where your health stands by making an appointment with your primary care physician. Don't have one? Find one at our Provider Directory: www.1199SEIUBenefits.org/find-a-provider. Visit the Healthy Living Resource Center for wellness tips, information and resources; 1199SEIUBenefits.org/healthyliving. Get to know your numbers at www.1199SEIUBenefits.org/healthyhearts. Need support managing chronic conditions such as type 2 diabetes, hypertension or overweight? Learn about our partnerships: visit www.1199SEIUBenefits.org/the-choice-is-yours/ Browse healthy recipes and meal-prep tips at 1199SEIUBenefits.org/food-as-medicine. For additional information and support, visit the National Kidney Foundation website, at Kidney.org, and the American Association of Kidney Patients, at www.aakp.org. For information about kidney donation, visit the Nation Kidney Registry page at KidneyRegistry.com Get inspired by fellow members through our Members' Voices series: 1199SEIUBenefits.org/healthyliving/membervoices. Stop by our Benefits Channel to join webinars on building healthy meals, managing stress and more: 1199SEIUBenefits.org/videos. Visit our YouTube channel to view a wide collection of healthy living videos: youtube.com/@1199SEIUBenefitFunds/playlists. Sample our wellness classes to exercise body and mind: 1199SEIUBenefits.org/wellnessevents. Guest Bio Kristin Meliambro, MD, is an Associate Professor in the Department of Medicine, Division of Nephrology at the Icahn School of Medicine at Mount Sinai. She earned her medical degree from the Icahn School of Medicine at Mount Sinai, and she completed both her internal medicine residency and clinical and research nephrology fellowships at the Mount Sinai Hospital. In addition to treating patients with a wide range of kidney diseases in diverse clinical settings, Dr. Meliambro is an NIH-funded physician-investigator who conducts basic and translational research with a focus on mechanisms of kidney podocyte injury and novel disease therapies. She is the co-Director of the Nephrology Division's Renal Biorepository, which banks biological specimens and collects clinical data from patients starting at the time of kidney biopsy and continuing longitudinally. She also actively participates as a PI and Co-Investigator in clinical trials testing novel agents for glomerular diseases. Dr. Meliambro also has a strong record of research mentorship of Associate Researchers and graduate/medical students in her lab, the majority of whom have been women and from under-represented minorities in science and medicine. Dr. Meliambro sees patients with a variety of kidney diseases, and she has a particular clinical interest in glomerular diseases. Her clinical responsibilities include the care of outpatients at the Mount Sinai Doctors nephrology practice, hemodialysis patients at Central Park Dialysis Center and inpatients at the Mount Sinai Hospital, where she also teaches and supervises nephrology fellows on the inpatient nephrology services.

Guests Manish Tanna, MD, Eugene Lin, MD, and Suzanne Watnick, MD, discuss the shift from privately-owned practices to large, consolidated facilities and its clinical impact on quality of life and patient outcomes with host Andrew Cohen, MD.

Guests Manish Tanna, MD, Eugene Lin, MD, and Suzanne Watnick, MD, discuss the shift from privately-owned practices to large, consolidated facilities and its clinical impact on quality of life and patient outcomes with host Andrew Cohen, MD.

For people living with kidney disease, clinical trials can offer hope—but not without questions or concerns. Today, we talk with Dr. Nadine Barrett, Glenda Roberts, and Luz Baqueiro about lived experience, community trust, and the power of being asked. In this episode we heard from:  Dr. Nadine J. Barrett is a Professor in the Department of Social Sciences and Health Policy in the Division of Public Health Sciences and the inaugural Senior Associate Dean of Community Engagement and Equity in Research at Wake Forest School of Medicine, she is Associate Director of Community Outreach and Engagement for Wake Forest Comprehensive Cancer Center, the Clinical Translational Science Institute and the Maya Angelou Center for Health Equity. Prior to joining Wake Forest, Dr. Barrett served 13 years in senior leadership roles at Duke University, as the Founding Director of both the Duke Center for Equity in Research and the nationally awarded, Duke Cancer Institute's Office of Health Equity. She is also President of the national Association of Cancer Care Centers, in Washington DC. A medical sociologist by training, Dr. Barrett is a health disparities researcher, expert equity strategist, and a nationally recognized leader in facilitating authentic community, healthcare, and academic partnerships to advance health equity. She develops multi-level interventions to address implicit bias, structural and systemic racism, and inequities that limit access to quality research and trustworthy health care among underserved and marginalized populations. Dr. Barrett brings an equity lens to her work and collaborations to enhance healthcare systems, close the disparities gap in health outcomes, and increase diverse and broad representation in research participation and the research workforce. Glenda Roberts: Prior to joining the Mount Sinai Center for Kidney Disease Innovation as the Director of Communications and Patient Engagement, Glenda V. Roberts was an Information Technology executive with over 35 years of experience with top-caliber corporations, including General Electric, Microsoft and Johnson & Johnson. She was also the Executive Director of the Seattle Transplant House, and the Director of External Relations & Patient Engagement at the University of Washington Center for Dialysis Innovation (CDI) and the Kidney Research Institute (KRI). Before going on dialysis, Glenda managed the progression of her disease for over 40 years using diet and exercise. Since her transplant in 2010, she's completed nine half marathons. Based upon her personal experience with kidney disease, Glenda is a passionate activist for kidney research and patients living with kidney disease. She's involved in myriad patient-centered national and international health care transformation initiatives.  All are focused on addressing patient preferences and improving patient-reported outcomes.   Glenda brings the patient voice to several NIH/NIDDK government and industry research efforts (Kidney Precision Medicine Project, APOLLO), as well as the American Society of Nephrology's Current & Emerging Threats (C-ET) Steering Committee. She's the inaugural co-chair of the Critical Path Institute's Biomarker Data Repository Governance Committee, and a member of the Kidney Health Initiative (KHI) Board of Directors. Additionally, she contributes to the Advisory Boards of LifeCenter Northwest and Home Dialyzors United, and over 15 other industry and academic research advisory committees/boards focused on transplantation, kidney, cardiovascular, and metabolic health. As an ambassador for the National Kidney Foundation, the American Kidney Fund, and the American Association of Kidney Patients, Glenda's advocacy tirelessly advances the voices, needs, and aspirations of the kidney community worldwide. Luz Baqueiro serves as a patient advocate with the National Kidney Foundation (NKF), providing feedback and helping develop new initiatives to better support the Latin American community affected by chronic kidney disease. She also raises awareness of the barriers faced by patients living with renal failure while educating and supporting her community in Georgia. In 2019, Luz was diagnosed with end-stage renal disease (ESRD). With limited resources  in Georgia, she relied on emergency in-hospital dialysis for a year. In August 2021, through self-determination, self-education, and the support of her family and community, she received a kidney transplant.   Additional Resources Clinical Trial Information Hub What is a Clinical Trial? Are Clinical Trials Safe?   Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.

In this special edition on Obesity as a Chronic Disease our host, Dr. Neil Skolnik will discuss epidemiology, pathophysiology and screening for CKD in People with Diabetes. This special episode is supported by an independent educational grant from Bayer. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Holly Kramer, M.D., Professor of Public Health Sciences and Medicine in the Division of Nephrology and Hypertension at Loyola University Chicago, past-president of the National Kidney Foundation, Editor-in-Chief of the National Kidney Foundation's journal,  Advances in Kidney Disease and Health (AKDH).   Selected references: Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026 . The American Diabetes Association's Standards of Care 2026, Diabetes Care 2026;49 (Supplement_1) :S246–S260  

Augusto Cesar Soares dos Santos Junior hosts the latest episode of the Global Kideny Care podcast, and this special episode is part of the offerings for NephMadness 2026. Augusto is joined by Ana Catalina Alvarez Elias: Renal Research Institute, Lili Chan: Mount Sinai, Neil Reza Evans: UC Davis Health, and Kuang-Yu Jen: UC Davis Health, where they discuss the emerging role of Artificial Intelligence in nephrology. AI stands out as a truly transformative force and is reshaping how diseases are diagnosed, how nephrologists interpret complex data, and understand patients. 

This episode includes authors from the recent AJHP theme issue on management of chronic kidney disease as well as pharmacists practicing in a variety of nephrology-related settings. The field of nephrology is evolving with new therapies and payment models, and pharmacists can positively impact patients throughout their continuum of kidney care. The panelists will discuss their impact on nephrology care and visions for the field.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This National Kidney Month, we celebrate the unsung heroes of the human body. Kidneys do so much more than filter blood (they've been described as the body's “cleaning crew” and “inventory managers”), so keeping them functioning well is vital to our overall health. Joining us to sing the praises of kidneys – and learn how to keep them healthy – is Dr. Kristin Meliambro, an Associate Professor in the Department of Medicine, Division of Nephrology at the Icahn School of Medicine at Mount Sinai. Dr. Meliambro walks us through the many essential jobs kidneys do for us and breaks down the various causes of kidney disease. She also shares practical lifestyle habits that support long-term kidney health.   The Takeaway We want to hear from you! Please complete our survey: org/member-feedback. Drop us a line at our social media channels: Facebook// Instagram // YouTube. Find out where your health stands by making an appointment with your primary care physician. Don't have one? Find one at our Provider Directory: www.1199SEIUBenefits.org/find-a-provider. Visit the Healthy Living Resource Center for wellness tips, information and resources; 1199SEIUBenefits.org/healthyliving. Get to know your numbers at www.1199SEIUBenefits.org/healthyhearts. Need support managing chronic conditions such as type 2 diabetes, hypertension or overweight? Learn about our partnerships: visit www.1199SEIUBenefits.org/the-choice-is-yours/ Browse healthy recipes and meal-prep tips at 1199SEIUBenefits.org/food-as-medicine. For additional information and support, visit the National Kidney Foundation website, at Kidney.org, and the American Association of Kidney Patients, at www.aakp.org. For information about kidney donation, visit the Nation Kidney Registry page at KidneyRegistry.com Get inspired by fellow members through our Members' Voices series: 1199SEIUBenefits.org/healthyliving/membervoices. Stop by our Benefits Channel to join webinars on building healthy meals, managing stress and more: 1199SEIUBenefits.org/videos. Visit our YouTube channel to view a wide collection of healthy living videos: youtube.com/@1199SEIUBenefitFunds/playlists. Sample our wellness classes to exercise body and mind: 1199SEIUBenefits.org/wellnessevents.   Guest Bio Kristin Meliambro, MD, is an Associate Professor in the Department of Medicine, Division of Nephrology at the Icahn School of Medicine at Mount Sinai. She earned her medical degree from the Icahn School of Medicine at Mount Sinai, and she completed both her internal medicine residency and clinical and research nephrology fellowships at the Mount Sinai Hospital. In addition to treating patients with a wide range of kidney diseases in diverse clinical settings, Dr. Meliambro is an NIH-funded physician-investigator who conducts basic and translational research with a focus on mechanisms of kidney podocyte injury and novel disease therapies. She is the co-Director of the Nephrology Division's Renal Biorepository, which banks biological specimens and collects clinical data from patients starting at the time of kidney biopsy and continuing longitudinally. She also actively participates as a PI and Co-Investigator in clinical trials testing novel agents for glomerular diseases. Dr. Meliambro also has a strong record of research mentorship of Associate Researchers and graduate/medical students in her lab, the majority of whom have been women and from under-represented minorities in science and medicine. Dr. Meliambro sees patients with a variety of kidney diseases, and she has a particular clinical interest in glomerular diseases. Her clinical responsibilities include the care of outpatients at the Mount Sinai Doctors nephrology practice, hemodialysis patients at Central Park Dialysis Center and inpatients at the Mount Sinai Hospital, where she also teaches and supervises nephrology fellows on the inpatient nephrology services.

Have you longed to integrate your Christian faith into your patient care—on the mission field abroad, in your work in the US, and during your training? Are you not sure how to do this in a caring, ethical, sensitive, and relevant manner? This “working” session will explore the ethical basis for spiritual care and provide you with professional, timely, and proven practical methods to care for the whole person in the clinical setting. https://www.dropbox.com/scl/fi/qpah9kh1lttg6cm1jjop9/Bob-Mason-Ethics-of-Spiritual-Care-revised.pptx?rlkey=0emve2ja8282nv8xc4uinq1hg&st=9033htwx&dl=0

Those who hope to honor God and advance Jesus' Kingdom face powerful opposition from spiritual, physical, and psychological enemies. Successful launching and long term fruitfulness depends on recognizing and, in dependence on the Holy Spirit, waging war against those enemies.

Medical missionaries often feel powerful emotional burden from moral injury, and it is a leading cause of departure from the mission field. But we have learned proven methods of preventing and dealing with moral injury. Use God’s powerful methods to protect yourself and your team, and to grow in wisdom and spirit!

Dr. Raeeda Gheewala is a double board-certified physician in Internal Medicine and Nephrology with over two decades of clinical experience. She has dedicated her career to advancing kidney health and exploring its vital connection to physical performance. As one of the few specialists in Sports Nephrology, Dr. Gheewala blends her expertise in kidney medicine with her passion for sports and wellness—helping athletes optimize hydration, recovery, and kidney function for peak performance. Beyond her clinical work, she advocates for prevention and proactive health, empowering individuals to protect their kidneys through informed lifestyle choices. Her patient-centered, holistic approach has earned her respect among colleagues and athletes alike. Dr. Gheewala continues to educate and inspire through her practice, speaking engagements, and online platform, where she shares evidence-based insights on how balanced living supports kidney and overall health. Some of the topics we discussed were: High-protein diets and supplementsHow athletes can balance performance nutrition with kidney preservationHow much protein to consume based on your level of activityVariability in protein intake per dayMyths about the safety of creatine supplements Advice for physicians or entrepreneurs who are interested in building their own practices in unique areasWhat athletes should know about hydration, heat illness, and kidney function Preventative measures to keep in mind for staying active in the summer heat And more! Interested in learning more about my telehealth direct specialty care practice? At AmazVita Wellness MD, I help patients optimize weight and metabolic health, harmonize hormones in peri/menopause, and enhance wellness and vitality. Accepting new patients now.amazvitamd@gmail.com or text (530) 332-8573 Learn more about me or schedule a FREE coaching call:https://www.joyfulsuccessliving.com/ Join the Voices of Women Physicians Facebook Group:https://www.facebook.com/groups/190596326343825/ Connect with Dr. Gheewala: Website: sportsnephrology.com Instagram: @thekidneyqueenmd TikTok: @sportskidneycoach Youtube: https://www.youtube.com/@KidneyQueenMD 

Description:  Hosts Roz and Dr. Sanchez-Fueyo are joined by Juan Pablo Huidobro to discuss the key articles of the February issue of the American Journal of Transplantation. Juan Pablo Huidobro is an Assistant Professor in Nephrology at Pontifical Catholic University of Chile [02:52] Evolving landscape of thrombotic microangiopathy in kidney transplant recipients in the post–C5 inhibitor era [13:22] Erythropoietin prolongs graft survival in mice by counteracting trained immunity [22:06] A new principle to attenuate ischemia reperfusion injury in kidney transplantation [33:14] Sustained allogeneic kidney graft operational tolerance despite discontinued conventional immunosuppression after CD19-CAR-T-cell therapy for relapsed/refractory post-transplantation lymphoproliferative disorder [40:15] Bloodstream Infection Subtypes and Characteristics Comparing Solid Organ Transplant and Non-Transplant Populations

I know 2026 feels like it ihas been here for months, but only a few weeks ago we were celebrating the nephrology accomplishments of 2025. The New Filtrate came together to review the year.The FiltrateJoel Topf‍ ‍@kidneyboy.bsky.social‬ (COI)Swapnil Hiremath @hswapnil.medsky.social and on LinkedIn Editor in Chief of Kidney International Case ReportsAnna Gaddy (@AnnaGaddy) Winner of NephJC Rookie of the Year 2020Nayan Arora (@CaptainChloride.bsky.social)AC (@medpeedskidneys.bsky.social)Vipin Verghese (@vipvargh.bsky.social) co-winner of NephJC Engaged Scientist of the Year in 2021Brian Rifkin (@brianrifkin.bsky.social) Co-Editor in Chief NephJC. Winner of NephJC Rookie of the Year 2021Cristina Popa (@NephroSeeker) Co-Editor in Chief NephJC. Wwinner of NephJC Rookie of the Year 2022 and MVP 2023Editing and Show Notes byAnna Gaddy and Joel TopfThe Kidney Connection written and performed by Tim YauShow NotesTop Stories in Nephrology 2025 (NephJC)First Top sories in Nephrology 2010! (Renal Fellow Network)Links to all of the Top Stories in Nephrology, hosted on NephJC since 2017 (NephJC)1. IgA NephropathyVISIONARY: Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial (NEJM)ORIGIN 3: A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy (NEJM)APPLAUSE-IgA Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy (NEJM)Aliza M. Thompson, MD, MS (ASN) 2. Lupus NephritisREGENCY: Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis (NEJM)3. Nobel prize winner and peripheral immune tolerance4. Xenotransplantation5. GLP1ra RevolutionRemodel REMODELing mechanistic trials for kidney disease: a multimodal, tissue-centered approach to understand the renal mechanism of action of semaglutide (Kidney International)SURPASS-CVOT Tirzepatide vs. Dulaglutide Is Associated with Reduced Major Kidney Events in Patients with Type 2 Diabetes, CVD, and Very High-Risk Kidney Diseases (Kidney Week abstract in JASN)Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford (KFF survey)6. GDMT implementation in CKD: lessons learnt from CONFIDENCE and MIRO-CKDConfidence Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (NEJM)MIRO-CKD Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trial (The Lancet)7. Flozin Meta analysisSMART-C. SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria. A Meta-Analysis (JAMA)SMART-C. Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria. A Meta-Analysis (JAMA)8. Paradigm Shift: Aiming for CKD Remission9. Fish Oil and DialysisPISCES Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis (NEJM)10. Decline in Dialysis Patients in the United StatesUSRD 2025 Annual Data Report (USRDS)Tubular SecretionSwapnil Hiremath Alien Earth on FX Hulu (Wikipedia)AC A Christmas Carol by Charles Dickens (Wikipedia) and The Muppet Christmas Carol (Wikipedia)Anna Monty Don (Wikipedia)Nayan Back Street Boys at The Sphere (Wikipedia)Brian Marty Supreme (Wikipedia)Cristina The Yellow Tie (Wikipedia)Vipin Stranger Things, good for a four year old? (Wikipedia)Joel Crash Course: The Universe with Katie Mack and John Green (Apple PodCasts)

Dr. Raeeda Gheewala is a double board-certified physician in Internal Medicine and Nephrology with over two decades of clinical experience. She has dedicated her career to advancing kidney health and exploring its vital connection to physical performance. As one of the few specialists in Sports Nephrology, Dr. Gheewala blends her expertise in kidney medicine with her passion for sports and wellness—helping athletes optimize hydration, recovery, and kidney function for peak performance. Beyond her clinical work, she advocates for prevention and proactive health, empowering individuals to protect their kidneys through informed lifestyle choices. Her patient-centered, holistic approach has earned her respect among colleagues and athletes alike. Dr. Gheewala continues to educate and inspire through her practice, speaking engagements, and online platform, where she shares evidence-based insights on how balanced living supports kidney and overall health. Some of the topics we discussed were:Why sports nephrology is importantHow Dr. Gheewala's sports nephrology practice addresses the unique kidney health risks faced by athletesThe best strategies for pain management in athletes with kidney concernsHow to determine how hydrated you areHydrating with electrolyte rich fluids, not just water, during a marathonEarly red flags that kidneys might be under stressHow athletes or active adults returning from injury can protect their kidneys during recoveryOne daily habit that supports both kidney health and pain-free performanceHow best to hydrate depending on level of kidney functioning And more! Interested in learning more about my telehealth direct specialty care practice? At AmazVita Wellness MD, I help patients optimize weight and metabolic health, harmonize hormones in peri/menopause, and enhance wellness and vitality. Accepting new patients now.amazvitamd@gmail.com or text (530) 332-8573 Learn more about me or schedule a FREE coaching call:https://www.joyfulsuccessliving.com/ Join the Voices of Women Physicians Facebook Group:https://www.facebook.com/groups/190596326343825/ Connect with Dr. Gheewala:Website: sportsnephrology.com Instagram: @thekidneyqueenmd TikTok: @sportskidneycoach Youtube: https://www.youtube.com/@KidneyQueenMD 

Is dialysis nephrology's greatest achievement or its original sin? In this Kidney Commute: Pit Stop episode, host Dr. Osama El Shamy, welcomes Dr. Andrew Cohen, to discuss a provocative question that challenges how the field of nephrology has evolved. Drawing from Dr. Cohen's recent AJKD publication, the conversation explores key historical milestones, including early innovations, the 1972 Medicare amendment, and the rise of corporatized dialysis care. Together, they examine how these forces have shaped trainee perceptions, workforce recruitment, and the identity of nephrology today. The episode concludes with a forward-looking discussion on how the field can refocus priorities, embrace innovation, and chart a more balanced path beyond dialysis-centered care. AJKD Article: https://www.ajkd.org/article/S0272-6386(25)00711-5/abstract